Company Overview of Thiakis Limited
Thiakis Limited develops biotechnology products such as TKS1225 which is an analogue of the peptide hormone oxyntomodulin, for the treatment of obesity and prevention and amelioration of diseases associated with excess weight such as type 2 diabetes. It develops medicines for the treatment of obesity, such as cardiovascular diseases, and metabolic diseases. The company was founded in 2004 and is based in London, United Kingdom. Thiakis Limited operates as a subsidiary of Pfizer Inc.
72 Hammersmith Road
London, W14 8TH
Founded in 2004
44 20 7470 5621
Key Executives for Thiakis Limited
Similar Private Companies By Industry
|Essen BioScience, Ltd.||Europe|
|Co-Tek (South-West) Ltd.||Europe|
|MorphoSys UK Ltd.||Europe|
|Point-2-Point Genomics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Thiakis Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.